This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 23-25, 2026
Hilton at Penn's LandingPhiladelphia, PA

Ted Huizenga
Senior Vice President, Chief Accounting Officer at Ultragenyx Pharmaceutical
Speaker

Profile

Ted Huizenga is SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. Since joining the company in 2014 during its IPO as a development-stage entity, Ted has supported scaling the organization into a global commercial biotech company. He currently maintains global oversight of the Accounting, Treasury, Internal Audit, and Finance Systems teams.

Prior to his tenure at Ultragenyx, Ted held key finance leadership roles at Crescendo Bioscience and RDV Corporation. He also was an Audit Manager within the Technology group at PwC. Ted holds a B.S. in Accounting from Calvin University and is a Certified Public Accountant (inactive) in Colorado.

Agenda Sessions

  • Financial Reporting Considerations When Transitioning From Clinical to Commercial

    4:30pm